Clinical interpretation of reticulocyte hemoglobin content, RET-Y, in chronic hemodialysis patients

Nephron - Clinical Practice

Volumn 111, Issue 4, 2009, Pages

  Ng, Hwee Yeong ^a,c   Chen, Hung Chun ^c   Pan, Lin Lin ^b   Tsai, Yu Che ^a   Hsu, Kao Tai ^a   Liao, Shang Chih ^a   Chuang, Fong Rong ^a   Chen, Jin Bor ^a   Lee, Chien Te ^a,d  

^a Division of Nephrology   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Anemia; Ferritin; Hemodialysis; RET Y; Transferrin saturation

Indexed keywords

ALBUMIN; ALUMINUM; ATOFEN; FERRITIN; HEMOGLOBIN; IRON; PARATHYROID HORMONE; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALUMINUM BLOOD LEVEL; ANEMIA; ARTICLE; CELL LEVEL; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; IRON BLOOD LEVEL; IRON DEFICIENCY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN CONTENT; RETICULOCYTE COUNT; RETICULOCYTE HEMOGLOBIN CONTENT; UREA NITROGEN BLOOD LEVEL;

ANEMIA, IRON-DEFICIENCY; FEMALE; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RETICULOCYTES; SENSITIVITY AND SPECIFICITY;

EID: 62049085738     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209151     Document Type: Article

References (28)

1. Ma JZ, Ebben J, Xia H, Collins AJ: Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999; 10: 610-619.
2. Hutchinson FN, Jones WJ: A cost-effectiveness analysis of anemia screening before erythropoietin in patients with end-stage renal disease. Am J Kidney Dis 1997; 29: 651-657.
3. Loge JP, Lange RD, Moore CV: Characterization of the anemia associated with chronic renal insufficiency. Am J Med 1958; 24: 4-18.
4. Fishbane S, Kowalski EA, Imbriano LJ, Maesaka JK: The evaluation of iron status in hemodialysis patients. J Am Soc Nephrol 1996; 7: 2654-2657.
5. National Kidney Foundation: IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 2001; 37(suppl 1):S182-S238.
6. Fishbane S, Frei GL, Maesaka J: Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 1995; 26: 41-46.
7. Macdougall IC, Tucker B, Thompson J, Tomson CR, Baker LR, Raine AE: A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 1996; 50: 1694-1699.
8. Fishbane S, Galgano C, Langley RC Jr, Canfield W, Maesaka JK: Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997; 52: 217-222.
9. Mast AE, Blinder MA, Lu Q, Flax S, Dietzen DJ: Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002; 99: 1489-1491.
10. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213.
11. McKenzie SB: General Aspects and Classifications of Anemia: Textbook of Hematology. Philadelphia, Williams & Wilkins, 1996, pp 101-102.
12. Aronoff GR. Safety of intravenous iron in clinical practice: implications for anemia management protocols. J Am Soc Nephrol. 2004; 15(suppl 2):S99-S106.
13. Hackeng CM, Beerenhout CM, Hermans M, Van der Kuy PH, Van der Dussen H, Van Dieijen-Visser MP, Hamulyák K, Van der Sande FM, Leunissen KM, Kooman JP: The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients. J Nephrol 2004; 17: 107-111.
14. Thomas C, Thomas L: Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002; 48: 1066-1076.
15. Franck S, Linssen J, Messinger M, Thomas L: Potential utility of Ret-Y in the diagnosis of iron-restricted erythropoiesis. Clin Chem 2004; 50: 1240-1242.
16. Buttarello M, Temporin V, Ceravolo R, Farina G, Bulian P: The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100: its use in the diagnosis and monitoring of posttreatment sideropenic anemia. Am J Clin Pathol 2004; 121: 489-495.
17. Brugnara C, Laufer MR, Friedman AJ, Bridges K, Platt O: Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. Blood 1994; 83: 3100-3101.
18. Kaneko Y, Miyazaki S, Hirasawa Y, Gejyo F, Suzuki M: Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients. Kidney Int 2003; 63: 1086-1093.
19. Brugnara C: Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003; 49: 1573-1578.
20. Tsuchiya K, Okano H, Teramura M, Iwamoto Y, Yamashita N, Suda A, Shimada K, Nihei H, Ando M: Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients. Clin Nephrol 2003; 59: 115-123.
21. Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999; 33: 63-72.
22. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD: Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004; 80: 299-307.
23. Chuang CL, Liu RS, Wei YH, Huang TP, Tarng DC: Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 70-377.
24. El-Khatib M, Duncan HJ, Kant KS: Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients. Nephrology (Carlton) 2006; 11: 400-404.
25. Kalantar-Zadeh K, Kopple JD: Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 2001; 38: 1343-1350.
26. Reddan DN, Frankenfield DL, Klassen PS, Coladonato JA, Szczech L, Johnson CA, Besarab A, Rocco M, McClellan W, Wish J, Owen JW Jr: Regional variability in anaemia management and haemoglobin in the US. Nephrol Dial Transplant 2003; 18: 147-152.
27. Brockenbrough AT, Dittrich MO, Page ST, Smith T, Stivelman JC, Bremner WJ: Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease. Am J Kidney Dis 2006; 47: 251-262.
28. Kuo CC, Lee CT, Chuang CH, Su Y, Chen JB: Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis. Clin Nephrol 2005; 63: 92-97.